ADENOCAINE Trademark

Trademark Overview


On Tuesday, May 16, 2017, a trademark application was filed for ADENOCAINE with the United States Patent and Trademark Office. The USPTO has given the ADENOCAINE trademark a serial number of 87451999. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, October 26, 2018. This trademark is owned by Hibernation Therapeutics, a KF LLC. The ADENOCAINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diseases of the cardiovascular system; pharmaceutical preparations for treating regional and global ischemia-reperfusion injury and arrhythmia management; cardioplegic compositions used in cardiac and coronary surgery; anti-inflammatory and anti-clotting preparations; pharmaceutical preparations for treatment of brain disease or injury; pharmaceutical preparations for treatment of hemorrhagic shock and for resuscitation; pharmaceutical preparations for treatment of cells, organs and tissues deprived of blood supply or oxygen; pharmaceutical preparations for body organ stabilization following traumatic injury and blood loss; pharmaceutical preparations for resuscitation; medical preparations for preserving organs and tissues; medical preparations for storing and protecting artery and vein grafts used for vascular and coronary artery bypass surgery or micro surgery
adenocaine

General Information


Serial Number87451999
Word MarkADENOCAINE
Filing DateTuesday, May 16, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, October 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating diseases of the cardiovascular system; pharmaceutical preparations for treating regional and global ischemia-reperfusion injury and arrhythmia management; cardioplegic compositions used in cardiac and coronary surgery; anti-inflammatory and anti-clotting preparations; pharmaceutical preparations for treatment of brain disease or injury; pharmaceutical preparations for treatment of hemorrhagic shock and for resuscitation; pharmaceutical preparations for treatment of cells, organs and tissues deprived of blood supply or oxygen; pharmaceutical preparations for body organ stabilization following traumatic injury and blood loss; pharmaceutical preparations for resuscitation; medical preparations for preserving organs and tissues; medical preparations for storing and protecting artery and vein grafts used for vascular and coronary artery bypass surgery or micro surgery

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 22, 2017
Primary Code005
First Use Anywhere DateThursday, June 20, 2013
First Use In Commerce DateThursday, June 20, 2013

Trademark Owner History


Party NameHibernation Therapeutics, a KF LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLos Angeles, CA 90024

Trademark Events


Event DateEvent Description
Friday, October 26, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, October 26, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION WRITTEN
Monday, March 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 2, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 21, 2017NON-FINAL ACTION E-MAILED
Monday, August 21, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 15, 2017ASSIGNED TO EXAMINER
Monday, May 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM